This study is currently not recruiting participants.
A Phase I Study to Assess the Pharmacokinetics Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to
Not Recruiting
1 years - 18 years
All
Phase
N/A
Brief description of study.
This is a study to find out more about a new drug, ceftazidime-avibactam (CAZ-AVI).
Detailed description of study
This is a study to find out more about a new drug, ceftazidime-avibactam (CAZ-AVI).
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Infections
Age:
1 years - 18 years
Gender: All
Updated on
22 Jul 2013.
Study ID: 1304011204
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
